Tongfang Kontafarma Holdings Limited (1312.HK)
1312.HK Stock Price Chart
Explore Tongfang Kontafarma Holdings Limited interactive price chart. Choose custom timeframes to analyze 1312.HK price movements and trends.
1312.HK Company Profile
Discover essential business fundamentals and corporate details for Tongfang Kontafarma Holdings Limited (1312.HK) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
18 Jan 2012
Employees
714.00
Website
https://www.tfkf.com.hkCEO
Feifei Wang
Description
Tongfang Kontafarma Holdings Limited, an investment holding company, engages in the manufacture and sale of prescription drugs and laboratory related products in Mainland China, Singapore, Taiwan, and the United States. The company operates in Pharmaceutical Business and Fitness Business segments. It also offers chemical drugs and prescribed traditional Chinese medicines; operates fitness centers; operates in the franchise business; and provides consultation services for fitness and health activities. The company trades in laboratory related products; researches and develops medical products; and offers corporate advisory services. As of December 31, 2021, it operated 12 fitness centers and 2 yoga center in Taiwan; and 10 fitness centers in Singapore. The company was formerly known as Allied Cement Holdings Limited and changed its name to Tongfang Kontafarma Holdings Limited in August 2016. The company was founded in 1993 and is headquartered in Wan Chai, Hong Kong. Tongfang Kontafarma Holdings Limited is a subsidiary of China Health Management Investment Limited.
1312.HK Financial Timeline
Browse a chronological timeline of Tongfang Kontafarma Holdings Limited corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 26 Aug 2025
Earnings released on 28 Mar 2025
EPS came in at -$0.01 , while revenue for the quarter reached $439.00M .
Earnings released on 28 Aug 2024
EPS came in at $0.00 , while revenue for the quarter reached $458.52M .
Earnings released on 28 Mar 2024
EPS came in at -$0.01 , while revenue for the quarter reached $378.40M .
Earnings released on 30 Aug 2023
EPS came in at $0.01 , while revenue for the quarter reached $430.71M .
Earnings released on 25 Mar 2023
EPS came in at -$0.00 , while revenue for the quarter reached $442.98M .
Earnings released on 29 Aug 2022
EPS came in at -$0.01 , while revenue for the quarter reached $451.09M .
Earnings released on 31 Dec 2021
EPS came in at $0.01 , while revenue for the quarter reached $502.90M .
Earnings released on 30 Jun 2021
EPS came in at -$0.01 , while revenue for the quarter reached $458.19M .
Earnings released on 31 Dec 2020
EPS came in at -$0.04 , while revenue for the quarter reached $297.96M .
1312.HK Stock Performance
Access detailed 1312.HK performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.